Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

PCRX holding history

Pacira BioSciences, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PCRX overviewAll 13F holders of PCRXFull Q2 2026 holdings

Shares (Q2 2026)
1,950,332
Value
$49.5M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of PCRX by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,950,332$49.5M<0.1%−32,392−1.6%ReducedHolders
Q1 20261,982,724$44.8M<0.1%−57,203−2.8%ReducedHolders
Q4 20252,039,927$52.8M<0.1%+97,784+5.0%AddedHolders
Q3 20251,942,143$50.0M<0.1%−311,222−13.8%ReducedHolders
Q2 20252,253,365$53.9M0.1%−10,544−0.5%ReducedHolders
Q1 20252,263,909$56.3M0.1%+6,435+0.3%AddedHolders
Q4 20242,257,474$42.5M<0.1%+300,536+15.4%AddedHolders
Q3 20241,956,938$29.5M<0.1%+1,476,508+307.3%AddedHolders
Q2 2024480,430$13.7M<0.1%+239,991+99.8%AddedHolders
Q1 2024240,439$7.03M<0.1%+34,423+16.7%AddedHolders
Q4 2023206,016$6.95M<0.1%+48,954+31.2%AddedHolders
Q3 2023157,062$4.82M<0.1%+151,753+2,858.4%AddedHolders
Q2 20235,309$212.7K<0.1%−13,723−72.1%ReducedHolders
Q1 202319,032$776.7K<0.1%+19,032NewHolders
Q2 20220$00.0%−11,651−100.0%Sold outHolders
Q1 202211,651$889.0K<0.1%−38,046−76.6%ReducedHolders
Q4 202149,697$2.99M<0.1%−30,036−37.7%ReducedHolders
Q3 202179,733$4.46M<0.1%−82,790−50.9%ReducedHolders
Q2 2021162,523$9.86M<0.1%−436,006−72.8%ReducedHolders
Q1 2021598,529$42.0M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.